May 18, 2018 / 5:04 AM / 9 days ago

BRIEF-Cosmo Pharmaceuticals: FDA Accepts New Drug Application Submission For Rifamycin SV MMX

May 18 (Reuters) - Cosmo Pharmaceuticals NV:

* FDA ACCEPTS NEW DRUG APPLICATION SUBMISSION FOR RIFAMYCIN SV MMX AND SETS PDUFA DATE FOR NOVEMBER 16, 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below